Register Now • San Diego Awards Gala →
CEO and Founder, Techstars
CEO and co-founder of BoostSuite
CEO of Foundry
President and CEO of the Central Indiana Corporate Partnership
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Chairman, CEO, & Founder, Alexandria Real Estate Equities
April 8, 2019 · Boston
May 21, 2019 · Boston
May 29, 2019 · San Diego
NKT Therapeutics is developing drugs that target a class of immune cells known as natural killer T cells.
Sponsored · Whitepaper
Implementing electronic solutions for risk mitigation
From Our Editors · Special Report
Facing an Uncertain Future
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.